ResMed Inc. Cash and Restricted Cash
ResMed Inc. (RSMDF) had Cash and Restricted Cash of $1.47 billion as of 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.47B.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.66B.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.42B.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.38B.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $1.47B 10-K · filed 2026-08-13 |
| 2026-03-31 | $1.66B 10-Q · filed 2026-05-01 |
| 2025-12-31 | $1.42B 10-Q · filed 2026-01-30 |
| 2025-09-30 | $1.38B 10-Q · filed 2025-10-31 |
| 2025-06-30 | $1.21B 10-K · filed 2026-08-13 |
| 2025-03-31 | $932.71M 10-Q · filed 2026-05-01 |
| 2024-12-31 | $521.94M 10-Q · filed 2026-01-30 |
| 2024-09-30 | $426.36M 10-Q · filed 2025-10-31 |
| 2024-06-30 | $238.36M 10-K · filed 2026-08-13 |
| 2024-03-31 | $237.91M 10-Q · filed 2025-04-24 |
| 2023-12-31 | $210.25M 10-Q · filed 2025-01-31 |
| 2023-09-30 | $209.10M 10-Q · filed 2024-10-25 |
| 2023-06-30 | $227.89M 10-K · filed 2026-08-13 |
| 2023-03-31 | $227.89M 10-Q · filed 2024-04-26 |
| 2022-12-31 | $253.20M 10-Q · filed 2024-01-25 |
| 2022-09-30 | $207.16M 10-Q · filed 2023-10-27 |
| 2022-06-30 | $273.71M 10-K · filed 2025-08-08 |
| 2022-03-31 | $201.77M 10-Q · filed 2023-04-28 |
| 2021-12-31 | $194.48M 10-Q · filed 2023-01-27 |
| 2021-09-30 | $276.15M 10-Q · filed 2022-10-28 |
| 2021-06-30 | $295.28M 10-K · filed 2024-08-09 |
| 2021-03-31 | $230.63M 10-Q · filed 2022-04-29 |
| 2020-12-31 | $255.87M 10-Q · filed 2022-01-28 |
| 2020-06-30 | $463.16M 10-K · filed 2023-08-11 |
| 2019-06-30 | $147.13M 10-K · filed 2022-08-12 |